July 23, 2021
Here’s a roundup of the latest news coverage from Drug Topics®.
Patients with diabetes and depression may have a lower risk of mortality and diabetes complications when taking antidepressants regularly, according to a new study.
July 21, 2021
In a recent webinar by Becton Dickinson, a panel of pharmacy experts discussed how hospital pharmacy departments can start and grow a robust analytics program.
Drug overdose deaths, including opioid-related deaths, have increased rapidly in the United States in recent years, according to preliminary data from the CDC.
July 20, 2021
Dapagliflozin was shown to significantly reduce the risk of kidney failure and prolong survival in patients with advanced chronic kidney disease regardless of diabetes status.
July 19, 2021
Here’s a preview of the featured content to watch for this week on Drug Topics®.
July 16, 2021
WSPA, NPCA, and NACDS fully support the court decision requiring CMS to reconsider the below-cost reimbursement plan.
July 15, 2021
The consumer products giant voluntarily recalled 4 NEUTROGENA® and 1 AVEENO® spray sunscreen products July 14 after internal testing found low levels of benzene, a carcinogen, in some product samples.
July 14, 2021
On June 2,2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls who have begun menstruating.
